CLINICAL_TRIALS
withdrawal
· 2021-08-26
Clinical Trial Update: Pessary as Adjunctive Therapy to Cerclage for the Prevention of Preterm Birth [Phase 3]
Summary
A Phase 3 clinical trial evaluating pessary as adjunctive therapy to cerclage for preventing preterm birth was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Federico II University | Conditions: Preterm Birth | Phase 3 | Status: WITHDRAWN